Literature DB >> 16100107

Magnesium and phosphate ions enable NAD binding to methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase.

Karen E Christensen1, I Ahmad Mirza, Albert M Berghuis, Robert E Mackenzie.   

Abstract

The mitochondrial NAD-dependent methylenetetrahydrofolate dehydrogenase-cyclohydrolase (NMDMC) is believed to have evolved from a trifunctional NADP-dependent methylenetetrahydrofolate dehydrogenase-cyclohydrolase-synthetase. It is unique in its absolute requirement for inorganic phosphate and magnesium ions to support dehydrogenase activity. To enable us to investigate the roles of these ions, a homology model of human NMDMC was constructed based on the structures of three homologous proteins. The model supports the hypothesis that the absolutely required Pi can bind in close proximity to the 2'-hydroxyl of NAD through interactions with Arg166 and Arg198. The characterization of mutants of Arg166, Asp190, and Arg198 show that Arg166 is primarily responsible for Pi binding, while Arg198 plays a secondary role, assisting in binding and properly orienting the ion in the cofactor binding site. Asp190 helps to properly position Arg166. Mutants of Asp133 suggest that the magnesium ion interacts with both Pi and the aspartate side chain and plays a role in positioning Pi and NAD. NMDMC uses Pi and magnesium to adapt an NADP binding site for NAD binding. This adaptation represents a novel variation of the classic Rossmann fold.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16100107     DOI: 10.1074/jbc.M505210200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Activation of biliverdin-IXalpha reductase by inorganic phosphate and related anions.

Authors:  Edward Franklin; Seamus Browne; Jerrard Hayes; Coilin Boland; Aisling Dunne; Gordon Elliot; Timothy J Mantle
Journal:  Biochem J       Date:  2007-07-01       Impact factor: 3.857

2.  Mitochondrial Methylenetetrahydrofolate Dehydrogenase (MTHFD2) Overexpression Is Associated with Tumor Cell Proliferation and Is a Novel Target for Drug Development.

Authors:  Philip M Tedeschi; Alexei Vazquez; John E Kerrigan; Joseph R Bertino
Journal:  Mol Cancer Res       Date:  2015-06-22       Impact factor: 5.852

3.  The catalytic mechanism of the mitochondrial methylenetetrahydrofolate dehydrogenase/cyclohydrolase (MTHFD2).

Authors:  Li Na Zhao; Philipp Kaldis
Journal:  PLoS Comput Biol       Date:  2022-05-25       Impact factor: 4.779

4.  Methylene tetrahydrofolate dehydrogenase/cyclohydrolase and the synthesis of 10-CHO-THF are essential in Leishmania major.

Authors:  Silvane M F Murta; Tim J Vickers; David A Scott; Stephen M Beverley
Journal:  Mol Microbiol       Date:  2009-01-16       Impact factor: 3.501

5.  The enzymes of the 10-formyl-tetrahydrofolate synthetic pathway are found exclusively in the cytosol of the trypanosomatid parasite Leishmania major.

Authors:  Tim J Vickers; Silvane M F Murta; Michael A Mandell; Stephen M Beverley
Journal:  Mol Biochem Parasitol       Date:  2009-04-05       Impact factor: 1.759

6.  Mitochondrial MTHFD2L is a dual redox cofactor-specific methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase expressed in both adult and embryonic tissues.

Authors:  Minhye Shin; Joshua D Bryant; Jessica Momb; Dean R Appling
Journal:  J Biol Chem       Date:  2014-04-14       Impact factor: 5.157

7.  The folate-coupled enzyme MTHFD2 is a nuclear protein and promotes cell proliferation.

Authors:  Nina Gustafsson Sheppard; Lisa Jarl; Diana Mahadessian; Laura Strittmatter; Angelika Schmidt; Nikhil Madhusudan; Jesper Tegnér; Emma K Lundberg; Anna Asplund; Mohit Jain; Roland Nilsson
Journal:  Sci Rep       Date:  2015-10-13       Impact factor: 4.379

8.  Human mitochondrial MTHFD2 is a dual redox cofactor-specific methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase.

Authors:  Minhye Shin; Jessica Momb; Dean R Appling
Journal:  Cancer Metab       Date:  2017-12-06

Review 9.  More Than a Metabolic Enzyme: MTHFD2 as a Novel Target for Anticancer Therapy?

Authors:  Zhiyuan Zhu; Gilberto Ka Kit Leung
Journal:  Front Oncol       Date:  2020-04-28       Impact factor: 6.244

10.  Engineering enzyme catalysis: an inverse approach.

Authors:  Clare F Megarity
Journal:  Biosci Rep       Date:  2019-02-12       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.